Candel Therapeutics (CADL) Non-cash Items (2020 - 2025)

Candel Therapeutics' Non-cash Items history runs 6 years deep, the most recent figure standing at $4.1 million for Q4 2025.

• In Q4 2025, Non-cash Items fell 85.15% year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $4.1 million (down 85.15% YoY), while the FY2025 annual figure was $4.1 million, down 85.15% from the prior year.
• Non-cash Items came in at $4.1 million for Q4 2025 at Candel Therapeutics, down from $11.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $27.6 million in Q4 2024 to a low of $199000.0 in Q4 2023.
• A 5-year average of $5.8 million and a median of $3.3 million in 2023 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items plunged 85.15% in 2021 and jumped 13768.84% in 2024, its largest moves.
• Candel Therapeutics' Non-cash Items stood at $2.1 million in 2021, then sank by 57.07% to $881000.0 in 2022, then plunged by 77.41% to $199000.0 in 2023, then surged by 13768.84% to $27.6 million in 2024, then tumbled by 85.15% to $4.1 million in 2025.
• According to Business Quant data, Non-cash Items over the past three periods registered $4.1 million, $11.4 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison